DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average – Should You Sell?

Shares of DarioHealth Corp. (NASDAQ:DRIO) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $11.62 and traded as low as $8.11. DarioHealth shares last traded at $8.11, with a volume of 10,455 shares.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of DarioHealth in a research report on Monday, December 29th. Stifel Nicolaus cut their price objective on DarioHealth from $16.00 to $10.00 and set a “buy” rating for the company in a research report on Friday, March 20th. Finally, Wall Street Zen lowered DarioHealth from a “hold” rating to a “sell” rating in a research note on Sunday, January 25th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $35.00.

DarioHealth Stock Down 4.0%

The firm has a market cap of $59.20 million, a PE ratio of -0.78 and a beta of 1.08. The company has a 50-day simple moving average of $10.27 and a 200-day simple moving average of $11.62. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.76 and a quick ratio of 3.30.

Institutional Trading of DarioHealth

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Kestra Advisory Services LLC purchased a new stake in DarioHealth in the fourth quarter worth $35,000. Geode Capital Management LLC grew its holdings in shares of DarioHealth by 167.9% in the fourth quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock worth $564,000 after purchasing an additional 31,063 shares during the last quarter. Finally, XTX Topco Ltd increased its stake in DarioHealth by 229.0% in the 2nd quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock worth $42,000 after buying an additional 43,513 shares during the period. Hedge funds and other institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.